Company Profiles

driven by the PitchBook Platform

Inbiomotion

Description

Developer of bio-markers to predict bone metastasis and improve the quality of life of cancer patients. The company is focused on the development of a diagnostic assay based on a selective single gene/protein bio-marker that predicts those patients at risk of suffering bone-specific metastases from primary tumors.

2010

Founded

PRIVATE

Status

1-10

Employees

Later Stage VC

Latest Deal Type

$2.44M

Latest Deal Amount

$4.95M

Total Amount Raised

Description

Developer of bio-markers to predict bone metastasis and improve the quality of life of cancer patients. The company is focused on the development of a diagnostic assay based on a selective single gene/protein bio-marker that predicts those patients at risk of suffering bone-specific metastases from primary tumors.

Website:

www.inbiomotion.com

Formerly Known As

Supragen

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Diagnostic Equipment

Other Industries

Medical Supplies
Monitoring Equipment

Primary Office

Av. Diagonal 601. 8º 08028 BarcelonaSpain +34 93 255 6115
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Inbiomotion's full profile, request a free trial.

Inbiomotion Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Inbiomotion Investors (6)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Caixa Capital RiscCorporate Venture CapitalMinority000 0000000 0000
ENISAGovernmentMinority000 0000000 0000
European CommissionGovernment000 0000000 0000
Fundació Vila CasasCorporationMinority000 0000000 0000
JV Risk TechnologiesCorporationMinority000 0000000 0000
Caixa Capital Risc Corporate Venture Capital
ENISA Government
European Commission Government
Fundació Vila Casas Corporation
JV Risk Technologies Corporation

Inbiomotion Executive Team (2)

NameTitleBoard
Seat
Contact
Info
Juan Tercero Ph.DHead, Product Development & Board Member
Anna Bosch Comas Ph.DCo-Founder
Juan Tercero Ph.D Head, Product Development & Board Member
Anna Bosch Comas Ph.D Co-Founder

Inbiomotion Board Members (6)

NameRepresentingRoleSinceContact
Info
David Lacey MDSelfBoard Member000 0000
Joël Jean-Mairet Ph.DYsios Capital PartnersGeneral Partner & Co-Founder000 0000
Jon Askaa Ph.DSelfBoard Member000 0000
José Antonio MesaCaixa Capital RiscInvestment Director000 0000
Juan Tercero Ph.DInbiomotionHead, Product Development & Board Member000 0000
David Lacey MD Board Member Self
Joël Jean-Mairet Ph.D General Partner & Co-Founder Ysios Capital Partners
Jon Askaa Ph.D Board Member Self
José Antonio Mesa Investment Director Caixa Capital Risc
Juan Tercero Ph.D Head, Product Development & Board Member Inbiomotion
Request full access to PitchBook